Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2023 Earnings Call Transcript

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2023 Earnings Call Transcript March 6, 2024

Adaptimmune Therapeutics plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Hello and welcome to Adaptimmune’s Fourth Quarter and Year-End Conference Call and Business Update. I will now turn the call over to Juli Miller. Juli, please go ahead.

Juli Miller: Good morning, thank you for joining us. Welcome to our Q4 and full-year...